Evaluation of Semen Quality following Kallikrein Treatment
作者:
Z.T. Homonnai,
M. Shilon,
G. Paz,
期刊:
Gynecologic and Obstetric Investigation
(Karger Available online 1978)
卷期:
Volume 9,
issue 2-3
页码: 132-138
ISSN:0378-7346
年代: 1978
DOI:10.1159/000300976
出版商: S. Karger AG
关键词: Kallikrein;Depot-Padutin;Sperm quality;Semen quality;Pregnancy rate
数据来源: Karger
摘要:
30 asthenozoospermic subfertile men were treated parenterally for 3 months with kallikrein. 20 men showed a significant increase in sperm motility, 66% (responders), while the other 10 men, 34% (non-responders), did not respond to this treatment. A striking decrease in sperm concentration (by 32%) was found in most patients. No latent period was found following kallikrein treatment. Thus, semen quality did not differ if examined immediately following the cessation of treatment or a few weeks afterwards. A poor pregnancy rate was recorded, i.e. 20% among the responders and 10% among the non-responders. In conclusion, kallikrein is a useful drug in the treatment of asthenozoospermia only when the sperm concentration is not decreased below the optimal value.
点击下载:
PDF
(1437KB)
返 回